Canopy Growth reported first-quarter fiscal 2027 net revenue of C$81.2 million, a 13% increase from the prior-year period, with year-over-year growth across its cannabis and Storz & Bickel businesses. Adjusted EBITDA loss narrowed 59% to C$3.2 million, and management reiterated its target of achieving positive adjusted EBITDA during fiscal 2027. Cannabis revenue increased 14%, led by 22% growth in Canadian medical cannabis and 10% growth in both adult-use and international markets. Adjusted consolidated gross margin improved to 31% from 25% a year earlier, while the company is targeting mid-30% margins in the near term and executing against C$8 million of annualized MTL Cannabis synergies. The company expects to begin shipping flower to the United Kingdom imminently, with revenue contributions anticipated in the second half of fiscal 2027.
Canopy Growth CorpRevenue up 13%, adjusted EBITDA loss narrowed 59%, and reiterated positive EBITDA target.
